Pharmacological management of vestibular migraine of childhood in a pediatric vestibular program

To compare the efficacy and tolerability of medications used to treat pediatric vestibular migraine.

Continue reading at PubMed →

Audiologists and vestibular specialists managing pediatric dizziness should note this retrospective comparison of drug options for childhood vestibular migraine, but prospective controlled trials are needed before changing prescribing practices — refer prescribing decisions to the treating physician.

Vestibular migraine is increasingly recognized as a leading cause of episodic vertigo in children, and real-world comparative data on pharmacological options from a dedicated pediatric vestibular program are valuable for multidisciplinary teams.

1. 01Retrospective study compared efficacy and tolerability of pharmacological treatments for vestibular migraine in a pediatric vestibular clinic population.
2. 02Vestibular migraine is one of the most common causes of episodic vertigo in children.
3. 03The study provides real-world data from a specialized pediatric vestibular program.
4. 04Both preventive and acute treatment options were likely compared across the patient cohort.
5. 05Limitations include retrospective design and absence of a placebo control group.

PMID

42906226

DOI

10.1016/j.ijporl.2026.113046.

Journal

International Journal of Pediatric Otorhinolaryngology

Publication type

research_article

Evidence level

4

Population

Children diagnosed with vestibular migraine seen in a pediatric vestibular program

Intervention

Pharmacological treatments for vestibular migraine (preventive and/or acute agents)

Comparator

Other pharmacological agents used within the same cohort